Literature DB >> 6593137

Treatment of myeloblastic sarcoma in the sacral canal with high-dose cytosine arabinoside.

M Barnett, M Richards, C Hamilton, A Lister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6593137     DOI： 10.1007/bf00269038

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  4 in total

1.  Chloroma and other myeloblastic tumors.

Authors:  H B Muss; W C Moloney
Journal:  Blood       Date:  1973-11       Impact factor: 22.113

2.  The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy.

Authors:  M L Slevin; E M Piall; G W Aherne; A Johnston; T A Lister
Journal:  Med Pediatr Oncol       Date:  1982

3.  Granulocytic sarcoma (chloroma), two years preceding myelogenous leukemia.

Authors:  T E Mason; R S Demaree; C I Margolis
Journal:  Cancer       Date:  1973-02       Impact factor: 6.860

4.  Granulocytic sarcoma (chloroma).

Authors:  P H Wiernik; A A Serpick
Journal:  Blood       Date:  1970-03       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.